SMTL ID : 8th4.1

Structure of AT118-L Nanobody Antagonist in Complex with the Angiotensin II Type I Receptor and Losartan

Coordinates

PDB Format Compare

Method

ELECTRON MICROSCOPY

Oligo State

hetero-1-1-1-1-mer

Ligands

1 x LSN: [2-butyl-5-chloranyl-3-[[4-[2-(2H-1,2,3,4-tetrazol-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol(Non-covalent)

LSN.1: 18 residues within 4Å: Chain A: Y.42, F.84, W.91, Y.94, T.95, S.112, V.115, S.116, L.119, A.170, R.174, F.189, K.206, I.402, Y.406 Chain D: S.102, N.103, P.104 14 PLIP interactions: 14 interactions with chain A Hydrophobic interactions: A:Y.42, A:F.84, A:W.91, A:V.115, A:V.115, A:V.115, A:L.119, A:I.402, A:I.402, A:Y.406 Hydrogen bonds: A:Y.42, A:R.174, A:R.174 pi-Cation interactions: A:K.206

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Skiba, M.A. et al., Antibodies expand the scope of angiotensin receptor pharmacology. Nat.Chem.Biol. (2024)

Release Date

2024-05-22

Peptides

Type-1 angiotensin II receptor Soluble cytochrome b562 complex: A
BAG2 Anti-BRIL Fab Heavy Chain: B
BAG2 Anti-BRIL Fab Light Chain: C
AT118-L Nanobody: D

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
C

C
D

D
B

Membrane

We predict this structure to be a membrane protein.
Show / Hide

Type-1 angiotensin II receptor Soluble cytochrome b562 complex

BAG2 Anti-BRIL Fab Heavy Chain

BAG2 Anti-BRIL Fab Light Chain

AT118-L Nanobody

Related Entries With Identical Sequence